Study of Immunogenicity Equivalence of a Homologous Third Dose of Covid-19 (Recombinante) Vaccine
Clinical trial NCT05142488 · UNKNOWN
Trial details
- NCT number
- NCT05142488
- Sponsor
- The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-09
- Primary completion
- 2022-03-30
- Enrollment
- 662
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.